Last reviewed · How we verify

NCT05840458

Pericapsular Nerve Block in Proximal Femoral Fractures

Status unknown Last updated 19 April 2024
What this trial tests

trial testing PENG Block in Femoral Fracture in 21 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorHospital Sirio-Libanes
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment21
Start date1 April 2023
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Sirio-Libanes

Who can join

Adults 18 to 105, any sex, with Femoral Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proximal femoral fractures commonly occur above 50 years and regional anesthesia could be a complement in the perioperative treatment of the patients. The use of pericapsular nerve group block (PENG Block) has been proposed to reduce pain. However, no studies have explored the efficient of the systemic analgesia associated with PENG Block in functional limitation in the preoperative period. In this sense, the main goal of this study is to evaluate the effectiveness of systemic analgesia associated with PENG Block in patients with proximal femoral fractures in the period preceding the surgical procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of PENG Block

Trials testing the same drug.

Other recruiting trials for Femoral Fracture

Currently open trials in the same condition.

Other Hospital Sirio-Libanes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05840458.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing